Home
Nighthawk Biosciences, Inc.

Nighthawk Biosciences, Inc. Market Share Analysis for May 2026

Industry: N/A

Domainnighthawkbio.com

Year Founded2008

Employees51 - 200

Annual Revenue$5M - $10M

Nighthawk Biosciences, Inc.

Nighthawk Biosciences, Inc. (including company regionals)

nighthawkbio.com

See more website traffic and engagement information

Nighthawk Biosciences, Inc. Revenue up to May 2026 is 5M - 10M

revenue generated by Nighthawk Biosciences, Inc. top domains

Nighthawk Biosciences, Inc. top domains revenue over 3 years

Revenue for Nighthawk Biosciences, Inc. top domains

nighthawkbio.com5M - 10M

See more with Sales Intelligence

Total visits to Nighthawk Biosciences, Inc.'s top domains

Understand Nighthawk Biosciences, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Nighthawk Biosciences, Inc.'s top domains

Analyze Nighthawk Biosciences, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Nighthawk Biosciences, Inc.'s top domains

See how Nighthawk Biosciences, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Nighthawk Biosciences, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Nighthawk Biosciences, Inc.

These are the website technologies, by industry, used by Nighthawk Biosciences, Inc. top domains

Mobile (2)

Meta Viewport

Email Services (1)

G Suite

Marketing (1)

Google Marketing Platform

Other (1)

Google API

More Technologies

1

See all

News & Signals from Nighthawk Biosciences, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNighthawk Biosciences, Inc. sells assets to Kopfkino in the amount of $1M.NightHawk Biosciences, Inc. sold its rights in an exclusive license agreement for certain cancer and disease treatment-related provisional patent applications and know-how to Kopfkino IP, LLC for $1,000,000.

NewsNighthawk Biosciences, Inc. receives financing of $3.25M.NightHawk receives proceeds of $3.25 million in connection with sale of non-core intellectual property and issuance of a low interest bearing note.

NewsNighthawk Biosciences, Inc. is developing mpox vaccine.NightHawk partnered with Lytic Solutions last summer to develop an mpox vaccine.